AU Stocks
US Stocks
US Options
Emerging Asia
Cash Management
Margin Lending
Smart Portfolio
MoneybullS
MCRB
Seres Therapeutics Inc
0.95
0.03+3.16%After Hours: 0.9400 -0.01 -0.95%16:39 05/20 EDT
OPEN/PREV CLOSE0.9153/0.9199
TODAY RANGE0.9100-0.9800
VOL2.05M
MARKET CAP143.72M
52 WEEK RANGE0.5400-6.73
AVG VOL (3M)4.96M
% TURNOVER1.35%
TURNOVER0
P/E (TTM)-1.5655
% RANGE7.61%
EPS(TTM)-0.6062
P/E(FORWARD)-0.8349
P/B-2.4056
BVPS-0.3945
DIVIDEND--
P/S1.014
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP142.92M
SHARES OUTSTANDING151.45M
NEXT EARNINGS08/06-08/12
FREE FLOAT150.60M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·05/09 17:22
Novo Nordisk, Flagship to develop next-generation obesity drugs
Dow Jones·05/09 17:00
Seres Therapeutics Is Maintained at Outperform by Oppenheimer
Dow Jones·05/09 17:00
Seres Therapeutics Price Target Cut to $4.00/Share From $5.00 by Oppenheimer
Benzinga·05/09 16:31
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jones·05/09 12:52
Seres Therapeutics Price Target Cut to $6.00/Share From $8.00 by Chardan Capital
Dow Jones·05/09 12:52
Seres Therapeutics Is Maintained at Buy by Chardan Capital
Reuters·05/09 12:11
SERES THERAPEUTICS <MCRB.O>: OPPENHEIMER CUTS TARGET PRICE TO $4 FROM $5
TipRanks·05/09 11:56
Oppenheimer Sticks to Their Buy Rating for Seres Therapeutics (MCRB)
Reuters·05/09 06:53
U.S. RESEARCH ROUNDUP-Crescent Energy, Rockwell Automation, Transdigm Group
Press release·05/09 03:05
Seres Therapeutics, Inc. Quarterly Report on Form 10-Q
Same Industry
Name/Symbol
Change%
Price